PRedictive Accuracy of Initial Stone Burden Evaluation.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Computed Tomography, CSD, Computed Tomography, SA, Computed Tomography, 3D.
- Who it may be relevant to
- Registry conditions: Urolithiasis, Ureterolithiasis, Nephrolithiasis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Belgium
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of Predictive Value of Different Stone Burden Measurements for Outcomes After Urinary Stone Treatment.
Overview
This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available. This imaging will be used to measure the stone burden in three different ways: in a single dimension (cumulative stone diameter), in two dimensions (surface area) and in three dimensions (volume).The primary purpose is to identify what way of measuring stone burden is most predictive of outcomes after stone treatment such as stone free status, operative time and complications.
Detailed description
The current EAU and AUA guidelines still base the recommendations for stone treatment on cumulative stone diameter, a linear measurement of the stone burden. Multiple nomograms rather use the stone burden's surface area to predict post-operative outcomes. More recently, volume has been prposed as the most accurate measure of stone burden and the variable to be reported in stone treatment literature. Although inuitively a three dimensional evaluation is most likely the most accurate representation of the stone burden to be treated.
Several reports however have compared different ways of measuring stone burden and could not confidently identify volume as the most accurate predictor of surgical outcomes.
With this study, we aim to prospectively collect data on a large group of patients that have a pre-operative CT scan available. This imaging will be used to assess the stone burden in different ways, linear, two dimensional and three dimensional. Both procedural and post-operative data will be collected to identify which of the measurements is most accurate in predicting outcomes such as stone free status, operative time and complications such as bleeding. Patients can be included regardless of the procedure that is proposed to treat the stone. After inclusion and after having undergone the procedure, at least one post-operative assessment is necessary to be able to evaluate the pre-operative variables against post-operative outcomes.
Interventions
- Diagnostic test Computed Tomography, CSD
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software - Diagnostic test Computed Tomography, SA
Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software - Diagnostic test Computed Tomography, 3D
Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Primary outcome measures
- Stone Free Status [Time frame: 1 day to 3 months]
Secondary outcome measures (2)
- Operative Time [Time frame: intra-operative]
- Complication [Time frame: 30 days]
Eligibility criteria
Inclusion criteria
- Availability of computed tomography imaging
- Undergoing any of the previously described procedures: extracorporeal shockwave lithotripsy, uretero(reno)scopy or percutaneous nephrolithotomy
- Able to read and understand the information regarding the study and able to provide informed consent
Exclusion criteria
- Under the stated age limit
- No pre-operative computed tomography imaging available
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Belgium · 1 center
- University Hospital Ghent — Ghent
Identifiers
NCT: NCT04746378 · BC-7295